Zacks Analyst Blog Highlights Research on Amgen, Thermo Fisher, PepsiCo, C&F Financial, and Acorn Energy
Zacks.com has recently highlighted stocks in its Analyst Blog, featuring research on companies such as Amgen Inc., Thermo Fisher Scientific Inc., PepsiCo, Inc., C&F Financial Corp., and Acorn Energy, Inc. These reports, chosen from about 70 reports published by Zacks analysts, provide insights into the companies' performances in their respective industries.
Amgen Inc.
Amgen's shares have significantly outperformed the Zacks Medical - Biomedical and Genetics industry with a +37% gain year-to-date compared to an industry gain of +12.1%. The company's second-quarter results surpassed expectations in both earnings and sales. Sales drivers include primary medicines like Evenity and newer medicines such as Imdelltra. However, sales of Prolia and Xgeva are declining due to biosimilar launches.
Thermo Fisher Scientific Inc.
Over the year-to-date period, shares of Thermo Fisher have exceeded the Zacks Medical - Instruments industry with gains of +8.8% against a drop of -6.3% in the industry. The company has benefited from improved customer activity and growth in pharma and biotech demand. The 2026 outlook has been raised due to better-than-expected second-quarter results, projecting an EPS of $25.12 on revenues of $47.80 billion.
PepsiCo, Inc.
PepsiCo has seen a +2% increase in shares year-to-date, contrasting with a +20.3% increase in the Zacks Beverages - Soft drinks industry. The company maintains a strong global presence, supported by its broad product portfolio. Despite challenges in North American demand and input costs, the 2026 guidance remains unchanged, suggesting management confidence.
C&F Financial Corp.
C&F Financial has outperformed its industry with an +18.6% gain compared to +14.6% in the Zacks Banks - Southeast industry. The company's diversified model supports earnings stability, although loan growth is surpassing deposit growth, increasing reliance on borrowing.
Acorn Energy, Inc.
Acorn Energy's shares have risen by +24.6%, despite facing potential volatility from lower telecom hardware shipments. The company focuses on strengthening recurring revenues through its monitoring services.
